Simplifying GMP CAR T and CAR NK cell therapy manufacturing processes [WEBINAR]

For more information, visit: https://www.miltenyibiotec.com/applic... Upscaling and streamlining manufacturing processes are key to ensure future successes in the clinic. In this webinar, we introduce and discuss our solutions for generating gene-modified CAR T and CAR NK cells in a standardized and fully automated fashion, with academic and industry end user panelists. We share insights about enabling easy translation and upscaling of CAR T and CAR NK cell manufacturing, harnessing closed system automation for manufacturing of CAR T and CAR NK cells, and finally we will discuss our solutions available for IPC/QC of cellular products including CAR T and NK cells.

Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has 2,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.